|
Volumn 31 Suppl 2, Issue , 2008, Pages
|
Should we prescribe statin and aspirin for every diabetic patient? Is it time for a polypill?
a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETYLSALICYLIC ACID;
ANTITHROMBOCYTIC AGENT;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
ARTICLE;
CARDIOVASCULAR DISEASE;
CLINICAL TRIAL;
CORONARY ARTERY DISEASE;
DIABETES MELLITUS;
DIABETIC ANGIOPATHY;
DRUG COMBINATION;
HUMAN;
RISK REDUCTION;
ASPIRIN;
CARDIOVASCULAR DISEASES;
CLINICAL TRIALS AS TOPIC;
CORONARY DISEASE;
DIABETES COMPLICATIONS;
DIABETIC ANGIOPATHIES;
DRUG THERAPY, COMBINATION;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
PLATELET AGGREGATION INHIBITORS;
RISK REDUCTION BEHAVIOR;
MLCS;
MLOWN;
|
EID: 41149166146
PISSN: None
EISSN: 19355548
Source Type: Journal
DOI: 10.2337/dc08-s253 Document Type: Article |
Times cited : (10)
|
References (0)
|